Dosidal · Switzerland

Vyxeos liposomal, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68014 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68014
atc: L01XY01
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2022-02-17
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01XY01
authorisation_number: 68014
form: PULPD
holder: Jazz Pharmaceuticals
holder_partner_nr: 1105689
it_number: 07.16.1.
name: Vyxeos liposomal, Pulver für ein Konzentrat zur Herstellung einer Infusionsdispersion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
2yd_7Ec2SX8CkB9xDb5QRwrJPjcFVKIJ4StslkigU3P1hRmlgTNCsOHknYz-xyBLkmpLjZOPhPyjToWZqHMyUA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68014 · Related records in other markets · Dosidal